One of the most common misconceptions about uterine fibroids is that they are rare. In reality, fibroids are extremely common, particularly during a woman’s reproductive years. Research shows that a significant percentage of women will develop fibroids by age 50, although not all will experience noticeable symptoms. At 1Fibroid, serving Manhattan, Queens, and Rego Park, NY, many patients are surprised to learn just how widespread this condition is.
Because fibroids are so common, it is important to normalize conversations about them. Some women may never know they have fibroids because their growths remain small and asymptomatic. Others may experience heavy menstrual bleeding, pelvic pressure, frequent urination, or lower back pain. The variation in symptoms can make fibroids seem less prevalent than they truly are, but awareness helps reduce stigma and encourages earlier evaluation.
Fibroids Are Not Cancer
Another widespread myth is that fibroids are cancerous or inevitably become cancer. Uterine fibroids are benign (noncancerous) tumors made of smooth muscle tissue. While a rare cancer called uterine sarcoma can occur, it is not the same as a typical fibroid and is uncommon. For most women, fibroids do not increase the risk of uterine cancer.
This misconception can create unnecessary fear. Women who receive a fibroid diagnosis often worry about malignancy, but the overwhelming majority of fibroids remain benign throughout a woman’s life. Proper imaging and medical evaluation help distinguish fibroids from other conditions. Open discussion with a healthcare provider can clarify individual risk factors and provide reassurance when appropriate.
Hysterectomy Is Not the Only Treatment
Many women believe that hysterectomy is the only effective treatment for fibroids. While hysterectomy permanently eliminates fibroids by removing the uterus, it is not the only option. Advances in medicine have expanded the range of treatments available, allowing for individualized care based on symptom severity, fibroid size, and reproductive goals.
Options may include medication to help manage heavy bleeding or shrink fibroids temporarily. Minimally invasive procedures such as Uterine Fibroid Embolization (UFE) can reduce fibroid size by cutting off their blood supply. Other techniques, including radiofrequency-based treatments, may target fibroids directly while preserving the uterus. For women who wish to maintain fertility, myomectomy removes fibroids while leaving the uterus intact. Understanding these alternatives helps women make informed choices rather than assuming major surgery is unavoidable.
Fibroids Do Not Always Cause Infertility
Another misconception is that fibroids automatically lead to infertility. While certain fibroids—especially those that distort the uterine cavity—can interfere with implantation or pregnancy, many women with fibroids conceive and carry healthy pregnancies without complications. The impact of fibroids on fertility depends largely on their size, number, and location.
Women who are trying to conceive and have been diagnosed with fibroids should seek individualized evaluation. In some cases, removing specific fibroids can improve fertility outcomes. In other cases, monitoring may be sufficient. It is important not to assume that a fibroid diagnosis means pregnancy is impossible.
Symptoms Should Not Be Ignored
Some women believe that heavy or painful periods are simply a normal part of life and do not require medical attention. While menstrual discomfort can be common, extremely heavy bleeding, prolonged cycles, or significant pelvic pain should not be dismissed. These symptoms may indicate fibroids or another underlying condition.
Early evaluation allows for more treatment options and may prevent complications such as anemia. Keeping track of menstrual changes and discussing them during routine appointments supports proactive care. Women should feel empowered to seek answers when symptoms interfere with daily life.
Knowledge Reduces Fear
Misinformation about fibroids can lead to unnecessary anxiety or delayed care. Understanding that fibroids are common, usually benign, and treatable helps women approach diagnosis and management with greater confidence. Education also supports better communication with healthcare providers and more thoughtful decision-making.
At 1Fibroid in Manhattan, Queens, and Rego Park, NY, increasing awareness about common misconceptions encourages women to ask questions and explore their options. Accurate information is one of the most powerful tools in supporting reproductive health and overall well-being.
Resources
Stewart, E. A., Cookson, C. L., Gandolfo, R. A., & Schulze-Rath, R. (2017). Epidemiology of Uterine Fibroids. Clinical Obstetrics and Gynecology.
Laughlin-Tommaso, S. K. (2018). Management of Uterine Fibroids. Obstetrics and Gynecology Clinics of North America.
Bulun, S. E. (2013). Uterine Fibroids. New England Journal of Medicine.